Skip to main content
TipRanks
Go Ultimate75% OFF

Ivan Bergstein Insider Profile

4 Followers

Ivan Bergstein, former CEO, Director at Stemline Therapeutics, holds 0.00 shares in Stemline Therapeutics (Ticker: STML).

Ivan Bergstein's Trading History

STML
Stemline Therapeutics
Jun 10, 2020―Uninformative Buy―$0.00
STML
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jun 10, 2020Uninformative Sell$0.003,024,336$0.00―
Jun 10, 2020Uninformative Buy$0.00220,000$0.00―
Apr 20, 2020Informative Sell$261.66K53,618$4.88―
Mar 13, 2020Informative Sell$286.21K57,451$4.98―
Feb 28, 2020Informative Sell$158.20K24,642$6.42―

You May Also Like

Ivan Bergstein insider profile FAQ

What is the percentage of profitable transactions made by Ivan Bergstein?
The percentage of profitable transactions made by Ivan Bergstein is 67%.
What is the average return per transaction made by Ivan Bergstein?
The average return per transaction made by Ivan Bergstein is -3.90%.
What stocks does Ivan Bergstein hold?
Ivan Bergstein holds: STML stocks.
What was Ivan Bergstein's most profitable transaction?
Ivan Bergstein’s most profitable transaction was an Informative Sell of STML stock on February 20, 2015. The return on the trade was 70.20%.
What is Ivan Bergstein's role in Stemline Therapeutics?
Ivan Bergstein's role in Stemline Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.